On July 1, 2018, Truman Company acquired a 70 percent interest in Atlanta Company in exchange for consideration of $838,075 in cash and equity securities. The remaining 30 percent of Atlanta’s shares traded closely near an average price that totaled $359,175 both before and after Truman’s acquisition.
In reviewing its acquisition, Truman assigned a $137,000 fair value to a patent recently developed by Atlanta, even though it was not recorded within the financial records of the subsidiary. This patent is anticipated to have a remaining life of five years.
The following financial information is available for these two companies for 2018. In addition, the subsidiary’s income was earned uniformly throughout the year. The subsidiary declared dividends quarterly.
Truman | Atlanta | ||||||
Revenues | $ | (711,290 | ) | $ | (550,000 | ) | |
Operating expenses | 413,000 | 372,000 | |||||
Income of subsidiary | (52,710 | ) | 0 | ||||
Net income | $ | (351,000 | ) | $ | (178,000 | ) | |
Retained earnings, 1/1/18 | $ | (896,000 | ) | $ | (598,000 | ) | |
Net income (above) | (351,000 | ) | (178,000 | ) | |||
Dividends declared | 170,000 | 70,000 | |||||
Retained earnings, 12/31/18 | $ | (1,077,000 | ) | $ | (706,000 | ) | |
Current assets | $ | 357,715 | $ | 531,000 | |||
Investment in Atlanta | 866,285 | 0 | |||||
Land | 481,000 | 234,000 | |||||
Buildings | 789,000 | 651,000 | |||||
Total assets | $ | 2,494,000 | $ | 1,416,000 | |||
Liabilities | $ | (917,000 | ) | $ | (390,000 | ) | |
Common stock | (95,000 | ) | (300,000 | ) | |||
Additional paid-in capital | (405,000 | ) | (20,000 | ) | |||
Retained earnings, 12/31/18 | (1,077,000 | ) | (706,000 | ) | |||
Total liabilities and stockholders' equity | $ | (2,494,000 | ) | $ | (1,416,000 | ) | |
How did Truman allocate Atlanta’s acquisition-date fair value to the various assets acquired and liabilities assumed in the combination?
How did Truman allocate the goodwill from the acquisition across the controlling and noncontrolling interests?
How did Truman derive the Investment in Atlanta account balance at the end of 2018?
Prepare a worksheet to consolidate the financial statements of these two companies as of December 31, 2018. At year-end, there were no intra-entity receivables or payables.
Part A
Consideration transferred by Truman |
$ |
838075 |
||
Non-controlling interest fair value |
359175 |
|||
Atlanta’s acquisition-date total fair value |
$ |
1197250 |
||
Book value of Atlanta |
(972000) |
|||
Fair value in excess of book value |
$ |
225250 |
||
Excess fair value assigned to specific accounts based on fair value |
Remaining life |
Annual excess Amortizations |
||
Patent |
137000 |
5 years |
27400 |
|
Goodwill |
$ |
88250 |
indefinite |
0 |
Total |
27400 |
Book value = common stock + additional paid in capital + retained earnings 1/1 + (net income *1/2)
= 300000+20000+598000+((178000-70000)*1/2) = 972000
Goodwill = Fair value in excess of book value-Patent
Part B
Controlling interest |
Non-controlling interest |
|||
Fair value at acquisition date |
$ |
838075 |
$ |
359175 |
Relative fair values of identifiable net assets 70% and 30% of $1109000 (acquisition date book value + patent = net asset fair value) |
776300 |
332700 |
||
Goodwill |
$ |
61775 |
$ |
26475 |
Part C
Initial value at acquisition date |
$ |
838075 |
Truman’s share of Atlanta’s net income for half year ([($178,000-27400 amortization) X ½ year] X 70%) |
52710 |
|
Dividends 2018 ($70,000 X ½ year X 70%) |
(24500) |
|
Investment account balance 12/31/18 |
$866285 |
Part D
TRUMAN COMPANY AND SUBSIDIARY ATLANTA COMPANY
Consolidated Worksheet
For the year ending December 31, 2018
Accounts |
Truman |
Altanta |
Consolidated entries |
Non controlling interest |
Consolidated totals |
|||||||
Debit |
Credit |
|||||||||||
Revenues |
$ |
(711290) |
$ |
(550000) |
(S) |
275000 |
$ |
$ |
(986290) |
|||
Operating expenses |
413000 |
372000 |
13700 |
186000 |
612700 |
|||||||
Net income to subsidiary |
(52710) |
52710 |
0 |
|||||||||
Separate company net income |
(351000) |
(178000) |
||||||||||
Consolidated net income |
(373590) |
|||||||||||
Net income attributable to NCI |
(22590) |
22590 |
||||||||||
Net income attributable to Truman |
(351000) |
|||||||||||
Retained earnings 1/1 |
(896000) |
(598000) |
598000 |
(896000) |
||||||||
Net income |
(351000) |
(178000) |
(351000) |
|||||||||
Dividends declared |
170000 |
70000 |
59500 |
10500 |
170000 |
|||||||
Retained earnings 12/31 |
(1077000) |
(706000) |
(1077000) |
|||||||||
Current assets |
357715 |
531000 |
888715 |
|||||||||
Investment in Atlanta |
866285 |
0 |
24500 |
890785 |
0 |
|||||||
Land |
481000 |
234000 |
715000 |
|||||||||
buildings |
789000 |
651000 |
1440000 |
|||||||||
Patent |
137000 |
13700 |
123300 |
|||||||||
goodwill |
88250 |
88250 |
||||||||||
Total assets |
2494000 |
1416000 |
3255265 |
|||||||||
Liabilities |
(917000) |
(390000) |
(1307000) |
|||||||||
Common stock |
(95000) |
(300000) |
300000 |
(95000) |
||||||||
Additional paid in capital |
(405000) |
(20000) |
20000 |
(405000) |
||||||||
Retained earnings 12/31 |
(1077000) |
(706000) |
(1077000) |
|||||||||
Noncontrolling interest 7/1 |
359175 |
(359175) |
||||||||||
Noncontrolling interest 12/31 |
(371265) |
(371265) |
||||||||||
Total liabilities and equity |
(2494000) |
(1416000) |
1509160 |
1509160 |
(3255265) |
550000/2 = 275000
27400/2 = 13700
372000/2 = 186000
70000/2*30% = 10500
(70000/2)+(70000/2*70%) = 59500
(70000/2*70%) = 24500
On July 1, 2018, Truman Company acquired a 70 percent interest in Atlanta Company in exchange...
On July 1, 2018, Truman Company acquired a 70 percent interest in Atlanta Company in exchange for consideration of $796,600 in cash and equity securities. The remaining 30 percent of Atlanta’s shares traded closely near an average price that totaled $341,400 both before and after Truman’s acquisition. In reviewing its acquisition, Truman assigned a $126,000 fair value to a patent recently developed by Atlanta, even though it was not recorded within the financial records of the subsidiary. This patent is...
On July 1, 2018, Truman Company acquired a 70 percent interest in Atlanta Company in exchange for consideration of $796,600 in cash and equity securities. The remaining 30 percent of Atlanta’s shares traded closely near an average price that totaled $341,400 both before and after Truman’s acquisition. In reviewing its acquisition, Truman assigned a $126,000 fair value to a patent recently developed by Atlanta, even though it was not recorded within the financial records of the subsidiary. This patent is...
On July 1, 2018, Truman Company acquired a 70 percent interest in Atlanta Company in exchange for consideration of $792,400 in cash and equity securities. The remaining 30 percent of Atlanta’s shares traded closely near an average price that totaled $339,600 both before and after Truman’s acquisition. In reviewing its acquisition, Truman assigned a $125,500 fair value to a patent recently developed by Atlanta, even though it was not recorded within the financial records of the subsidiary. This patent is...
On July 1, 2018, Truman Company acquired a 70 percent interest in Atlanta Company in exchange for consideration of $789,250 in cash and equity securities. The remaining 30 percent of Atlanta’s shares traded closely near an average price that totaled $338,250 both before and after Truman’s acquisition.In reviewing its acquisition, Truman assigned a $136,500 fair value to a patent recently developed by Atlanta, even though it was not recorded within the financial records of the subsidiary. This patent is anticipated...
On July 1, 2018, Truman Company acquired a 70 percent interest in Atlanta Company in exchange for consideration of $820,575 in cash and equity securities. The remaining 30 percent of Atlanta’s shares traded closely near an average price that totaled $351,675 both before and after Truman’s acquisition. In reviewing its acquisition, Truman assigned a $133,000 fair value to a patent recently developed by Atlanta, even though it was not recorded within the financial records of the subsidiary. This patent is...
On July 1, 2018, Truman Company acquired a 70 percent interest in Atlanta Company in exchange for consideration of $820,575 in cash and equity securities. The remaining 30 percent of Atlanta’s shares traded closely near an average price that totaled $351,675 both before and after Truman’s acquisition. In reviewing its acquisition, Truman assigned a $133,000 fair value to a patent recently developed by Atlanta, even though it was not recorded within the financial records of the subsidiary. This patent is...
On July 1, 2018, Truman Company acquired a 70 percent interest in Atlanta Company in exchange for consideration of $794,850 in cash and equity securities. The remaining 30 percent of Atlanta's shares traded closely near an average price that totaled $340,650 both before and after Truman's acquisition In reviewing its acquisition, Truman assigned a $134,500 fair value to a patent recently developed by Atlanta, even though it was not recorded within the financial records of the subsidiary. This patent is...
On July 1, 2018, Truman Company acquired a 70 percent interest in Atlanta Company in exchange for consideration of $767,200 in cash and equity securities. The remaining 30 percent of Atlanta's shares traded closely near an average price that totaled $328,800 both before and after Truman's acquisition. In reviewing its acquisition, Truman assigned a $138,500 fair value to a patent recently developed by Atlanta, even though it was not recorded within the financial records of the subsidiary. This patent is...
On July 1, 2018, Truman Company acquired a 70 percent interest in Atlanta Company in exchange for consideration of $829,500 in cash and equity securities. The remaining 30 percent of Atlanta's shares traded closely near an average price that totaled 355,500 both before and after Truman's acquisition. In reviewing its acquisition, Truman assigned a $127,500 fair value to a patent recently developed by Atlanta, even though it was not recorded within the financial records of the subsidiary. This patent is...
On July 1, 2018, Truman Company acquired a 70 percent interest in Atlanta Company in exchange for consideration of $835,275 in cash and equity securities. The remaining 30 percent of Atlanta's shares traded closely near an average price that totaled $357,975 both before and after Truman's acquisition. In reviewing its acquisition, Truman assigned a $140,000 fair value to a patent recently developed by Atlanta, even though it was not recorded within the financial records of the subsidiary. This patent is...